STOCKSCREENR
Log In

ELUT

NASDAQ

Elutia Inc.

$1.09+0.02(+1.87%)Mkt Cap: $46.64M

Key Stats

Market Cap

$46.64M

P/E Ratio

-1.68

EPS

$-0.65

Dividend Yield

0.00%

52-Week Range

$0.50 — $3.46

Volume

100.47K

Avg Volume

329.88K

Beta

0.69

Valuation

P/E (TTM)

-1.68

Forward P/E

—

PEG Ratio

0.00

P/S (TTM)

3.75

P/B (TTM)

1.67

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-2.26%

ROA (TTM)

0.86%

ROIC

—

Gross Margin

0.54%

Operating Margin

-1.50%

Net Margin

—

Debt/Equity

0.27

Current Ratio

2.22

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.08%

EPS Growth (5Y)

-0.16%

Sales Growth (3Y)

-0.16%

Sales Growth (5Y)

-0.07%

EPS Est (This Year)

$-0.51

EPS Est (Next Year)

$-0.38

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$0.85

Analyst Consensus

Price Target Range

$5.00$10.00$10.50
LowMedianHigh

Consensus Target: $8.88(714.7% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

42.70M

Float

31.34M

Free Float %

73.40%

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

IPO Date

2020-10-08

Employees

51

CEO

C. Randal Mills

Index Membership

—

Website

https://elutia.com

Elutia Inc. (ELUT) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $46.64M, a P/E ratio of -1.68, ELUT is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ELUT against other stocks using dozens of fundamental and technical filters.

Similar Stocks

OBI.L

Ondine Biomedical Inc.

$11.00

+0.00%

$47.11M

IMMP

Immutep Limited

$0.41

-12.96%

$59.61M

OABI

OmniAb, Inc.

$1.83

+0.00%

$208.29M

CGEN

Compugen Ltd.

$2.27

+0.00%

$214.64M

CNTN

Canton Strategic Holdings Inc

$3.95

-2.47%

$156.14M

AARD

Aardvark Therapeutics, Inc. Common Stock

$5.33

-0.56%

$116.05M

Frequently Asked Questions

What is Elutia Inc.'s P/E ratio?

Elutia Inc. (ELUT) has a trailing twelve-month (TTM) P/E ratio of -1.68. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Elutia Inc. pay a dividend?

No, Elutia Inc. (ELUT) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Elutia Inc.'s market cap?

Elutia Inc. (ELUT) has a market capitalization of $46.64 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.